Skip to content

Clinical efficacy and safety of prostatic periapical triangle block for transperineal cognitive fusion prostate biopsy and rectal hydrogel spacer injection.

Clinical efficacy and safety of prostatic periapical triangle block for transperineal cognitive fusion prostate biopsy and rectal hydrogel spacer injection. - Clinical efficacy and safety of prostatic periapical triangle block for transperineal cognitive fusion prostate biopsy and rectal hydrogel spacer injection.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041610
Enrollment
190
Registered
2020-08-31
Start date
2020-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

1-1. Only PAT block for transperineal cognitive fusion prostate biopsy 1-2. PAT block, percutaneous lidocaine and prilocaine patch and intrarectal lidocaine gel for transperineal cognitive fusion pros

Sponsors

Department of Urology, Saitama Medical Center, Saitama Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. 20 years old or greater, PSA > 4 ng/ml, positive multi parametric MRI, and men who need a prostate biopsy 2. 20 years old or greater, histopathologically confirmed prostate cancer, and men who need radiotherapy (IMRT, brachytherapy)

Exclusion criteria

Exclusion criteria: Patients who have difficulty communicating due to mental disorders, patients with a history of perineal/rectal surgery and difficulty in transrectal ultrasound insertion, and patient with rectal invasion of prostate cancer

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS)

Secondary

MeasureTime frame
Operation time Complications

Countries

Japan

Contacts

Public ContactHideki Takeshita

Saitama Medical Center, Saitama Medical University Department of Urology

takeuro@saitama-med.ac.jp81492283673

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026